cl-316243 and Teratogenesis

cl-316243 has been researched along with Teratogenesis* in 1 studies

Other Studies

1 other study(ies) available for cl-316243 and Teratogenesis

Article	Year
Evaluating the teratogenicity of the selective ß3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay). Drug and chemical toxicology, 2017, Volume: 40, Issue:1 Topics: Adrenergic beta-3 Receptor Agonists; Animals; Dioxoles; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Embryonic Development; Lethal Dose 50; No-Observed-Adverse-Effect Level; Teratogenesis; Toxicity Tests; Xenopus laevis	2017

Article

Year

Evaluating the teratogenicity of the selective ß3-adrenoceptor agonist, CL 316.243 hydrate by employing FETAX (frog embryo teratogenesis assay).

Drug and chemical toxicology, 2017, Volume: 40, Issue:1

Topics: Adrenergic beta-3 Receptor Agonists; Animals; Dioxoles; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Embryonic Development; Lethal Dose 50; No-Observed-Adverse-Effect Level; Teratogenesis; Toxicity Tests; Xenopus laevis

2017